logo
welcome
The Motley Fool

The Motley Fool

Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker

The Motley Fool
Summary
Nutrition label

79% Informative

CRISPR Therapeutics has made incredible progress in the past five years .

The company earned approval for Casgevy , a gene-editing treatment for two blood-related disorders, last year .

The biotech should turn a profit in the next five years or so -- and maintain solid revenue and earnings growth.

But there's plenty of downside potential too, including the potential failure of its leading pipeline candidates.

CRISPR Therapeutics wasn't one of the 10 best stocks for investors to buy now.

The 10 stocks that made the cut could produce monster returns in the coming years .

Consider when Nvidia made this list on April 15, 2005 ... if you invested $ 1,000 at the time of our recommendation, you’d have $ 657,306 !.

VR Score

77

Informative language

77

Neutral language

9

Article tone

semi-formal

Language

English

Language complexity

48

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

medium-lived

External references

9

https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=b3512bdf-4381-455d-8270-0224155f7c20&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26amp%253Bsource%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D13885&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=42a675f7-dab1-4bac-b1d5-956f9ebd5057https://www.fool.com/terms/b/blockbuster-drug/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=42a675f7-dab1-4bac-b1d5-956f9ebd5057https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=b3512bdf-4381-455d-8270-0224155f7c20&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fe-foolcom-sa-bbn-dyn%3Faid%3D8867%26source%3Disaeditxt0010895%26ftm_cam%3Dsa-bbn-evergreen%26ftm_pit%3D13885%26ftm_veh%3Darticle_pitch_feed_yahoo%26company%3DCRISPR%2520Therapeutics&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=42a675f7-dab1-4bac-b1d5-956f9ebd5057https://www.fool.com/legal/fool-disclosure-policy/https://ycharts.comhttps://ycharts.com/companies/CRSP/total_return_forward_adjusted_pricehttps://www.fool.com/investing/stock-market/market-sectors/healthcare/biotech-stocks/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=42a675f7-dab1-4bac-b1d5-956f9ebd5057https://www.fool.com/investing/2024/08/04/prediction-crispr-therapeutics-stock-could-be-a-mi/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=42a675f7-dab1-4bac-b1d5-956f9ebd5057https://www.fool.com/author/20111/

Affiliate links

no affiliate links